Results 191 to 200 of about 53,199 (230)
Some of the next articles are maybe not open access.
Reactions Weekly, 2009
The ubiquitin-mediated degradation of proteins in numerous cellular processes, such as turnover and quality control of proteins, cell cycle and apoptosis, transcription and cell signaling, immune response and antigen presentation, and inflammation and development makes the ubiquitin-proteosome systems a very interesting target for various therapeutic ...
+7 more sources
The ubiquitin-mediated degradation of proteins in numerous cellular processes, such as turnover and quality control of proteins, cell cycle and apoptosis, transcription and cell signaling, immune response and antigen presentation, and inflammation and development makes the ubiquitin-proteosome systems a very interesting target for various therapeutic ...
+7 more sources
Hematology Meeting Reports, 2009
An increasing number of novel therapies are changing the landscape in oncology – the majority of which are novel biologicals with distinct mechanism from conventional cytotoxics. In the last decades, the discovery of the ubiquitin-proteasome pathway in eukaryotic organisms has revolutionized the understanding of cellular processes indispensable for ...
openaire +1 more source
An increasing number of novel therapies are changing the landscape in oncology – the majority of which are novel biologicals with distinct mechanism from conventional cytotoxics. In the last decades, the discovery of the ubiquitin-proteasome pathway in eukaryotic organisms has revolutionized the understanding of cellular processes indispensable for ...
openaire +1 more source
DMW - Deutsche Medizinische Wochenschrift, 2006
S, Simons, M E, Scheulen, U, Jaehde
openaire +3 more sources
S, Simons, M E, Scheulen, U, Jaehde
openaire +3 more sources
Progress on the Application of Bortezomib and Bortezomib-Based Nanoformulations
Biomolecules, 2022Jianhao Liu +2 more
exaly